Filing Details

Accession Number:
0001181431-12-024937
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-04-19 21:44:50
Reporting Period:
2012-01-10
Filing Date:
2012-04-19
Accepted Time:
2012-04-19 20:44:50
Original Submission Date:
2012-01-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
928054 Flotek Industries Inc FTK Miscellaneous Chemical Products (2890) 900023731
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1347364 E Jesse Neyman 2930 W. Sam Houston Pkwy. N Ste. 300
Houston TX 77043
Exec Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-01-10 5,200 $2.51 70,615 No 4 X Direct
Common Stock Disposition 2012-01-10 5,200 $12.50 65,415 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2012-01-10 5,200 $2.51 5,200 $2.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
298,114 2012-02-16 2015-02-15 No 4 X Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $13.81 2008-03-13 2013-03-12 3,070 3,070 Direct
Common Stock Stock Option $22.75 2009-02-28 2014-02-27 5,784 8,854 Direct
Common Stock Stock Option $2.51 2010-02-16 2015-02-15 44,460 53,314 Direct
Common Stock Stock Option $2.30 2010-08-11 2014-08-10 150,000 203,314 Direct
Common Stock Stock Option $9.19 2012-04-08 2017-04-07 100,000 303,314 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2013-03-12 3,070 3,070 Direct
2014-02-27 5,784 8,854 Direct
2015-02-15 44,460 53,314 Direct
2014-08-10 150,000 203,314 Direct
2017-04-07 100,000 303,314 Direct
Footnotes
  1. Exercise of 5,200 share at $2.51 per share and Sale of 5,200 shares at $12.50 per share, pursuant to a Rule 10b5-1 Trading Plan.